Real Imaging Receives CE Mark for “Real Imager 8” – Breast Cancer Screening System
Wednesday, May 21, 2014
Airport City, Israel., May 21, 2014 – Real Imaging Ltd. today announced that it has received CE Mark designation for its Real Imager 8 device intended for use as adjunct breast cancer screening modality. Real Imaging is the first company to introduce an imaging-based risk assessment system that utilizes 3D functional non-invasive metabolic imaging of the breast. The device objectively assess the risk and likelihood that the woman harbors a breast cancer by assessing several imaging biomarkers associated with malignancy.